Matt Taylor


Healthcare, Pharma & Biotech

+1 561 399 2085

Matt Taylor joined Jefferies in 2022 to lead US Medical Supplies & Devices research. Previously, he spent four years at UBS, leading US Medtech coverage and serving as Head of US Healthcare Research. Before UBS, he spent nine years at Barclays covering the sector after starting his career at BMO Capital Markets in 2007. He has been ranked in Institutional Investor and recognized as an “Up and Comer”. Matt holds the CFA designation, a BS in Biomedical Engineering from Boston University, and an MBA from Fordham University, including its Beijing MBA program.

What We Are Known For:

Deep expertise & differentiated sector insights, spanning development pipelines, MedTech, healthcare services, aged care, PHI & key Australian healthcare companies.

Thought leadership on major industry themes, including clinical trials, GLP-1 impacts, tariffs, utilization, pricing, inflation, consent decrees, warning letters & litigation trends.

Extensive company access and primary research, supported by 50+ annual calls, physician and expert networks, in-person doctor days, and conference engagement.

Broad and experienced coverage platform, covering 20 healthcare names with deep sector experience and strong collaboration across our global healthcare team.

Proprietary deep dives and thematic research, delivering detailed analysis of companies, industry events, and evolving market dynamics.